Proteomics International: Raises $6M for high-tech blood test

  • Proteomics International (PIQ) has received firm commitments to undertake a $6 million share placement
  • 12.5 million shares will issued to sophisticated and professional investors at 48 cents each
  • Additionally, the company will issue 2.2 million options to Euroz Hartleys Securities and Candour Advisory
  • These options will have an exercise price of 75 cents with expiry two years after issue
  • Proteomics will also use the funds to manufacture, market, and speed-up regulatory approvals for its PromarkerD test and strengthen its balance sheet
  • Proteomics is up 9 per cent on the market with shares trading for 60 cents each
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Spektr Strengthens Compliance Efforts with $20M Funding

Fintech startup Spektr secures $20 million for AI-driven compliance solutions.Highlights: Spektr raises $20 million to enhance its AI...

Hacked DeFi Platform Drift Secures Funds to Repay Customers

Drift plans to relaunch with Tether support after addressing security issues.Highlights: Drift DeFi platform has secured funds after...

Business Banking Fintech Slash Reaches Unicorn Status

The fintech startup achieves a valuation of over $1 billion.Highlights: Slash has been valued at over $1 billion.The...

Amex Strengthens Digital Services with AI Expense Management Acquisition

American Express to acquire Hyper to enhance its business offerings.Highlights: American Express announces the acquisition of AI startup...